Skip to content

A prospective, single-center, single-group clinical trial to evaluate efficacy and safety of laparoscopic assisted radical gastrectomy for distal gastric cancer

A prospective, single-center, single-group clinical trial to evaluate efficacy and safety of laparoscopic assisted radical gastrectomy for distal gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075848
Enrollment
Unknown
Registered
2023-09-18
Start date
2023-09-18
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

test group:KangDuo abdominal endoscopic surgical system

Sponsors

Harbin Medical University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The pathological diagnosis was lower gastric cancer with stages I, II and III; (2) After comprehensive evaluation, it is suitable for radical distal subtotal gastrectomy; (3) Age 18-75 years old, gender unlimited; (4) Be able to cooperate with and complete follow-up and related examinations; (5) Voluntarily participate in the study and sign the informed consent

Exclusion criteria

Exclusion criteria: (1) Clinical and imaging examination revealed extensive metastasis of abdominal cavity or other organs. (2) There are serious uncontrolled acute infections. (3) accompanied by important organ failure, can not tolerate general anesthesia. (4) Gastric cancer with perforation, bleeding, obstruction and other emergency operations. (5) Severe coagulation dysfunction, obvious bleeding tendency. (6) Combined with serious mental disorders, can not cooperate. (7) Pregnant or lactating women. (8) Participants in other investigational drug or device clinical trials have not been completed. (9) The researcher thinks that it is not suitable to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
Surgical non-conversion rate;

Secondary

MeasureTime frame
Number of lymph node dissection;Surgeon satisfaction;

Countries

China

Contacts

Public ContactWang Kuan

Harbin Medical University Cancer Hospital, 150 Haping Road, Nan'gang District, Harbin, Heilongjiang

88008008@sina.com+86 139 3624 3918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026